Pfizer (PFE) stock vs the S&P 500 and pharmaceutical stocks
As of 2 October 2026, Pfizer (PFE) is beating both the S&P 500 and pharmaceutical stocks as a group (PPH) over the past three months.
Where Pfizer stands now
As of 2 October 2026, Pfizer is still ahead of the S&P 500 over three months, but it gave back ground over the past month.
Inside its group, PFE leads: it is ahead of pharmaceutical stocks (PPH) over both the past month and three months. As a group, pharmaceutical stocks are losing ground to the S&P 500 right now. The group is in transition, so the stock's place inside it matters more than usual.
Pfizer is 5.2% of PPH, so its moves weigh on the fund. It sits in 3 of the sector and theme funds Zensei tracks. The thing to watch is the gap to its group: as long as it stays ahead of both the market and its peers, the trend is intact.
PFE vs the S&P 500: returns
Pfizer and the S&P 500 (SPY) side by side, over each window Zensei tracks.
Prices as of · computed from daily adjusted closes · how we measure
PFE against pharmaceutical stocks, in depth
See the size of the gap between Pfizer and pharmaceutical stocks (PPH) over every window, its momentum and its relative strength, and where it sits among pharmaceutical stocks.
See the full analysisWhich ETFs hold Pfizer?
3 funds that Zensei tracks hold PFE, by weight. The fund with the largest weight is its sector on this page.
Pfizer competitors
The largest other holdings of VanEck Pharmaceutical ETF (PPH), with their return over the past month.
Pfizer stock: common questions
Is Pfizer stock beating the S&P 500?
As of 2 October 2026, Pfizer (PFE) is down 2.6% over the past month. The S&P 500 is up 1.3% over the same month. Over three months, the stock is up 16.3% and the S&P 500 is up 3.6%.
Which ETFs hold Pfizer?
As of 2 October 2026, 3 funds that Zensei tracks hold PFE. Its largest weight is in VanEck Pharmaceutical ETF (PPH), at 5.2%. It is also in Health Care Select Sector SPDR (XLV, 2.6%), SPDR S&P 1500 Momentum Tilt ETF (MMTM, 0.2%).
Who are Pfizer's competitors?
As of 2 October 2026, the largest other holdings of VanEck Pharmaceutical ETF (PPH) are Eli Lilly (LLY), Merck & Co Inc (MRK), Novartis AG (NVS), Novo Nordisk (NVO), Bristol-Myers Squibb Co (BMY). These are the stocks Pfizer sits next to among pharmaceutical stocks.
Is Pfizer doing better than other pharmaceutical stocks?
As of 2 October 2026, Pfizer (PFE) is ahead of pharmaceutical stocks as a group (PPH) over the past three months. Zensei Edge shows the size of the gap, its momentum and its relative strength.
Track Pfizer against pharmaceutical stocks and the market
Zensei Edge maps 100+ sectors and themes against the S&P 500, with each stock inside them measured against its group.